Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation
- 1 June 1997
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 67 (6) , 1046-1053
- https://doi.org/10.1016/s0015-0282(97)81437-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The effects of post-ovulatory administration of onapristone on the development of a secretory endometriumHuman Reproduction, 1996
- Leukaemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free mediumHuman Reproduction, 1996
- Leukaemia inhibitory factor in human endometrium throughout the menstrual cycleJournal of Endocrinology, 1996
- Endometrial protein PP14: a new test of endometrial function?Reproductive Medicine Review, 1994
- Mifepristone (RU 486) Compared with High-Dose Estrogen and Progestogen for Emergency Postcoital ContraceptionNew England Journal of Medicine, 1992
- Blastocyst implantation depends on maternal expression of leukaemia inhibitory factorNature, 1992
- Suppression by Human Placental Protein 14 of Natural Killer Cell ActivityAmerican Journal of Reproductive Immunology, 1991
- New steroids with antiprogestational and antiglucocorticoid activitiesSteroids, 1984
- NAD+-dependent 15-hydroxyprostaglandin dehydrogenase activity in human endometriumProstaglandins, 1980
- A description of 34 human ova within the first 17 days of developmentJournal of Anatomy, 1956